Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG

Approval Number

SIN15178P

Drug Name

CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG

Product Name

CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG

Approval Date

February 20, 2017

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

C09DA04

ATC Item Name

irbesartan and diuretics

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

Macleods Pharmaceuticals Limited

Active Ingredients

Ingredient Name

Hydrochlorothiazide

Strength

12.50mg

Drug MonographHydrochlorothiazide

Ingredient Name

Irbesartan

Strength

300.00mg

Drug MonographIrbesartan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG - HSA Approval | MedPath